Suzhou Zelgen Biopharmaceuticals Co. Ltd. Class A 688266

As global markets experience mixed performances, with Japan's stock markets declining and China's manufacturing sector showing modest improvement, investors are increasingly turning their attention to the potential opportunities within Asian equities. In this environment, identifying undervalued stocks can be a strategic move, as these investments may offer significant upside potential when market conditions stabilize or improve.